Author: Global Health

  • All
  • Advocacy Hub
  • Advocacy Update
  • Blog Posts
  • GHC Announcements
  • News Center
  • Statement
Advocacy Update ~ November 6, 2017

This post was written by Danielle Heiberg, Senior Advocacy Manager, and Melissa Chacko, Policy Associate, Global Health Council.

Introduction of Congressional Resolutions to End AIDS in Children
The bipartisan, bicameral resolutions “Recognizing the importance of a continued commitment to ending pediatric AIDS worldwide,” were introduced late last month by Senators Marco Rubio (R-FL) and Bob Casey (D-PA) and Congresswomen Ileana Ros-Lehtinen (R-FL), and Barbara Lee (D-CA). These four members of Congress were joined by 27 bipartisan peers as original co-sponsors of the resolutions. In a press release statement, Charles Lyon, President and CEO of Elizabeth Glaser Pediatric AIDS Foundation, said, “The introduction of these resolutions puts a spotlight on children and the global AIDS response, but also the important role Congress plays in ensuring that the burden of AIDS is ended in children once and for all.” Read EGPAF’s statement.

Redesign Consensus: A Plan for U.S. Assistance
As uncertainty surrounding proposed foreign aid cuts and redesign, or reorganization, of federal agencies still remains in the air, a number of development and foreign policy experts devised separate proposals on more effective organizational structures primarily focused on  USAID and the State Department and the efficient use of foreign assistance. Authors of six of these plans came together to create a unified approach to achieve an empowered U.S. development function. The “Redesign Consensus: A Plan for U.S. Assistance” is a unified set of practical recommendations and steps that the administration and Congress can take to strengthen effectiveness and coherence to the U.S. aid architecture. Read Redesign Consensus proposal.

USAID Administrator Testifies on Accountable Soft Power in the National Interest
In early November, USAID Administrator Mark Green testified before the House State, Foreign Operations, and Related Programs subcommittee in an oversight hearing on the role of soft power in national interests. With the President’s proposal of 30 percent budget cuts to foreign aid, the hiring freeze at USAID, and lack of focus and engagement in potential conflict zones, the committee reviewed the recent accountability of U.S. foreign affairs. A range of issues were covered, with only a few questions specifically on global health. Congresswoman Nita Lowey (D-NY) questioned the justification for the expansion of the Mexico City Policy to all global health programs, and asked Administrator Green for the data on the impact of the expansion. He indicated that USAID is currently working on a review of the first six months of the expanded policy, and would share the final report with Congress.

Global Health Security Agenda extended to 2024
In late October, during the Global Health Security Agenda (GHSA) Ministerial meeting, partner countries, including the United States, agreed to extend the GHSA to 2024. The GHSA is a growing partnership of 50 nations, international organizations, and non-government stakeholders focused on building countries’ capacity to combat infectious diseases and to elevate global health security as a national and international priority. Learn more about GHSA.

Where is HER voice in the Global Fund’s next Executive Director?

This post originally appeared on the Women in Global Health website. This guest post was written by Kelly Thompson, Ann Keeling, Roopa Dhatt, and Caity Jackson from Women in Global Health. Established in 2015, Women in Global Health (WGH) was founded with the values of being a movement. WGH works with other global health organizations to encourage stakeholders from governments, civil society, foundations, academia and professional associations and the private sector to achieve gender equality in global health leadership in their space of influence. 

**Update: The original version of this blog featured data points from 2008 and early 2017. The graphic has been updated to reflect the most recent data from the GFATM Secretariat.

Infographic Courtesy: Women in Global Health

Last Tuesday, without much fanfare, The Global Fund to Fight, AIDS, Tuberculosis and Malaria (GFATM) unceremoniously announced the 4 short-listed candidates for its next Executive Director (ED). In contrast to the World Health Organization’s (WHO) recent attempts at developing a more transparent and open process for the selection of their Director General, the GFATM process has been shrouded in secrecy. The first attempt to select its ED, set to replace Dr. Mark Dybul, who stepped down in May, was abruptly aborted. With rumors swirling and one of the candidates, Helen Clark, suddenly removing her candidacy, the GFATM Board noted that due to problems encountered in the recruitment process they were going to draw that round to a conclusion and restart the process (1). In this new round, 3 men and 1 woman have been shortlisted, also harkening back to the WHO election where gender parity was not reached in the final candidates. There is also a startling lack of geographical diversity in the final candidates with two from the United Kingdom, and one each from the USA and Tanzania.  

In one way, we should not be surprised that the shortlist is dominated by men, every previous ED has been a man, with the exception of Dr. Marijke Wijnroks, who is currently serving as the Interim ED. But since women are the majority of the workforce in the sectors of health the GFATM covers it is surprising that the shortlist is not 3 women and 1 man or at least 50/50 women and men. In the lead up to the second round the names of some outstanding women leaders in global health were circulating as being in the race. Talented women are out there and we should be surprised that the final shortlist is not gender balanced. It goes without saying that whoever is selected, regardless of gender, needs to have a strong understanding of the interplay of gender within the three diseases and how to apply a gender transformative approach to their leadership.

The GFATM’s own 2017 report notes the variety of ways in which the three diseases are gendered (2). Some of the key examples include, in some parts of Africa, young women (15-24 years old) are eight times more likely than young men to be living with HIV, and in the hardest hit countries 80% of new HIV infections are among adolescent girls. Those same adolescent girls are also more likely to be impacted by tuberculosis. Whilst malaria greatly affects pregnant women and children under 5, in some areas, like the Mekong, malaria greatly impacts men, who make up the migrant and mobile population. GFATM has adjusted its funding and programming to reflect these gender needs, with 60% of current investments being targeted at women and girls, and the announcement of the HER Voice fund to be launched in November 2017. However, as noted by Hawkes, et al there are still major gaps in transforming this policy into reality and often ‘too few grant agreements are found to specify, fund or monitor gender-sensitive or transformative activities’ (3).

We urge the Board to prioritise these considerations in the ED’s selection:

1) Strong development background and connection with the reality of the context of the GFATM’s work.
2) Strong commitment to gender equality essential to delivering GFATM’s work and Universal Health Coverage (UHC).
3) Commitment to reform of the GFATM including promoting diverse leadership.
4) Commitment to partnerships and building/engaging civil society particularly from the global south.

In closing, we ask all ED candidates, how will you address gender equality in the Global Fund?  

(1) Zarocostas, John. Controversy embroils selection of new Global Fund head The Lancet , Volume 389 , Issue 10072 , e3.

(2) Results Report 2017. The Global Fund.

(3) Hawkes, Sarah. Gender blind? An analysis of global public-private partnerships for health. Globalization and Health 201713:26

2017 Global Health Landscape Symposium (GHLS 17) Social Media Toolkit

December 8, 2017
FHI 360 Conference Center
1825 Connecticut Ave. NW, 8th Floor
Washington, DC, 20009 United States
@GlobalHealthOrg  #GHLS17


Global Health Council (GHC)’s Global Health Landscape Symposium (GHLS17) is a one-day conference that will convene policy and program leads from global health organizations across multiple sectors. GHLS17 will encourage the asking and answering of difficult questions our sector faces about the current global health landscape and the future of global health.  We’re excited to announce that registration for this event is OPEN! View the GHLS17 webpage for the latest updates on speakers, agenda, and more.

As GHC members and partners, we hope that you can spread the word about registration, and promote this landmark event through your social media networks. Below is a selection of prepared tweets and Facebook posts for you to use as they are, or please feel free to personalize them. Remember to tag @GlobalHealthOrg (Twitter) and @globalhealthcouncil (Facebook), and utilize the hashtag #GHLS17. For questions, please contact

Timeline:  November 3, 2017 – December 5, 2017.                 

Sample Tweets:

1) [SHARE] Join @GlobalHealthOrg’s #GHLS17 to brainstorm #globalhealth solutions as a collective voice!

2) [SHARE] Excited for @GlobalHealthOrg’s #GHLS17? Share ideas to navigate the #globalheath landscape! 

3) [SHARE] Looking forward to hearing #globalhealth voices speak up @GlobalHealthOrg’s #GHLS17! 

4) [SHARE] What works? What doesn’t? Find out @GlobalHealthOrg’s #GHLS17 on Dec. 8. Register by Dec. 5: 

5) [SHARE] Participants from @COREGroupDC, @CGDev, @WorldVision & more @GlobalHealthOrg’s #GHLS17!

6) [SHARE] Tickets are running out for @GlobalHealthOrg’s #GHLS17 so register now! Deadline is Dec. 5.


Sample Facebook/Instagram posts:

1) [SHARE] Are you excited for Global Health Council’s [@globalhealthcouncil’s] Global Health Landscape Symposium? This landmark event will bring the voices of both speakers and participants to the forefront. Get ready to brainstorm #globalhealth solutions as one collective voice! More information on registration is available: #GHLS17 

2) [SHARE] Don’t miss out on an opportunity to attend Global Health Council’s [@globalhealthcouncil’s] #GHLS17 on December 8! Why? Because you could become part of the collective voice that will drill down on barriers and best practices to address changes in the global health landscape. Come and share ideas to better navigate the fluid #globalhealth landscape. Register today! 

3) [SHARE] Time is ticking to register for Global Health Council’s [@globalhealthcouncil’s] #GHLS17! This one-day event will convene policy and program leads from #globalhealth organizations across multiple sectors and encourage crucial conversations that drill down on barriers and best practices to address changes in the global health landscape. Curious to know what the agenda is? Check it out: 

4) [SHARE] In a changing #globalhealth landscape, we need to figure out what works. Register today and join @globalhealthcouncil’s #GHLS17 to engage with participants from @COREGroupDC, @WorldVisionInternational, @CGDev, and more! Updated information on the agenda and registration is available now:



PATH Center for Malaria Control and Elimination (CMCE) launches “A Conceptual Framework for Malaria Elimination”

The PATH Center for Malaria Control and Elimination (CMCE) launched A Conceptual Framework for Malaria Elimination, a new report in the PATH Malaria Learning Series.

Building directly upon the WHO Elimination Framework, the report describes the steps to elimination as a practical approach for national malaria programs as they move along the continuum of decreasing malaria transmission intensity. These steps aim to help program managers and team members think about how to best deploy the tools at their disposal according to their country’s malaria transmission strata (from high to very low) and varying ecologic, epidemiologic, and societal features.

GHTC Releases New Global Health R&D Introductory Fact Sheet Series

GHC member GHTC released a new four-part introductory fact sheet series about the importance of global health research and development (R&D). The series explores why global health R&D is vital to achieving a healthier world, the historical gains achieved, and the health, security, and economic returns from investing in global health R&D.

View the fact sheet series here:





Additionally, GHTC also released another fact sheet series examining how US government agencies contribute to global health R&D. Each fact sheet explores how the agency engages in global health R&D, the distribution of the agency’s R&D investments across health areas, and the impact generated by its work, including examples of R&D success stories.

United States Agency for International Development (USAID) Fact Sheet

National Institute of Health (NIH) Fact Sheet

The US Centers for Disease Control and Prevention (CDC) Fact Sheet

U.S. Department of Defense (DoD) Fact Sheet

The Biomedical Advanced Research and Development Authority (BARDA) Fact Sheet

The U.S. Food and Drug Administration (FDA) Fact Sheet